Resultados da busca - Berglund, Peter
- Mostrando 1 - 20 resultados de 27
- Ir para a próxima página
-
1
-
2
-
3
-
4
-
5
-
6
Reduced DNA methylation and psychopathology following endogenous hypercortisolism – a genome-wide study por Glad, Camilla A. M., Andersson-Assarsson, Johanna C., Berglund, Peter, Bergthorsdottir, Ragnhildur, Ragnarsson, Oskar, Johannsson, Gudmundur
Publicado em 2017Texto -
7
Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors por Albershardt, Tina C., Leleux, Jardin, Parsons, Andrea J., Krull, Jordan E., Berglund, Peter, ter Meulen, Jan
Publicado em 2020Texto -
8
Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translation por Pavon-Eternod, Mariana, David, Alexandre, Dittmar, Kimberly, Berglund, Peter, Pan, Tao, Bennink, Jack R., Yewdell, Jonathan W.
Publicado em 2013Texto -
9
LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response por Albershardt, Tina Chang, Campbell, David James, Parsons, Andrea Jean, Slough, Megan Merrill, ter Meulen, Jan, Berglund, Peter
Publicado em 2016Texto -
10
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memory por Leleux, Jardin A., Albershardt, Tina C., Reeves, Rebecca, James, Reice, Krull, Jordan, Parsons, Andrea J., ter Meulen, Jan, Berglund, Peter
Publicado em 2021Texto -
11
HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells por Wee, Edmund G., Ondondo, Beatrice, Berglund, Peter, Archer, Jacob, McMichael, Andrew J., Baltimore, David, ter Meulen, Jan H., Hanke, Tomáš
Publicado em 2017Texto -
12
Structural brain changes in hyperthyroid Graves’ disease: protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden—the CogThy project por Holmberg, Mats Olof, Malmgren, Helge, Berglund, Peter, Bunketorp-Käll, Lina, Heckemann, Rolf A, Johansson, Birgitta, Klasson, Niklas, Olsson, Erik, Skau, Simon, Nystrom Filipsson, Helena
Publicado em 2019Texto -
13
RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles por Xu, Jing, Luft, J. Christopher, Yi, Xianwen, Tian, Shaomin, Owens, Gary, Wang, Jin, Johnson, Ashley, Berglund, Peter, Smith, Jonathan, Napier, Mary E., DeSimone, Joseph M.
Publicado em 2013Texto -
14
Rendering Protein-Based Particles Transiently Insoluble for Therapeutic Applications por Xu, Jing, Wang, Jin, Luft, J. Christopher, Tian, Shaomin, Owens, Gary, Pandya, Ashish A., Berglund, Peter, Pohlhaus, Patrick, Maynor, Benjamin W., Napier, Mary E., DeSimone, Joseph M.
Publicado em 2012Texto -
15
In Vitro and In Vivo Characterization of MicroRNA-Targeted Alphavirus Replicon and Helper RNAs por Kamrud, Kurt I., Coffield, V. McNeil, Owens, Gary, Goodman, Christin, Alterson, Kim, Custer, Max, Murphy, Michael A., Lewis, Whitney, Timberlake, Sarah, Wansley, Elizabeth K., Berglund, Peter, Smith, Jonathan
Publicado em 2010Texto -
16
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer por Morse, Michael A., Hobeika, Amy C., Osada, Takuya, Berglund, Peter, Hubby, Bolyn, Negri, Sarah, Niedzwiecki, Donna, Devi, Gayathri R., Burnett, Bruce K., Clay, Timothy M., Smith, Jonathan, Lyerly, H. Kim
Publicado em 2010Texto -
17
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects por Osada, Takuya, Berglund, Peter, Morse, Michael A., Hubby, Bolyn, Lewis, Whitney, Niedzwiecki, Donna, Yang, Xiao Yi, Hobeika, Amy, Burnett, Bruce, Devi, Gayathri R., Clay, Timothy M., Smith, Jonathan, Kim Lyerly, H.
Publicado em 2012Texto -
18
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio por Crosby, Erika J, Hobeika, Amy C, Niedzwiecki, Donna, Rushing, Christel, Hsu, David, Berglund, Peter, Smith, Jonathan, Osada, Takuya, Gwin III, William R, Hartman, Zachary C, Morse, Michael A, Lyerly, Herbert Kim
Publicado em 2020Texto -
19
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern por Hawman, David W., Meade-White, Kimberly, Archer, Jacob, Leventhal, Shanna, Wilson, Drew, Shaia, Carl, Randall, Samantha, Khandhar, Amit P., Hsiang, Tien-Ying, Gale, Michael, Berglund, Peter, Fuller, Deborah Heydenburg, Feldmann, Heinz, Erasmus, Jesse H.
Publicado em 2021Texto -
20
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern por Hawman, David W, Meade-White, Kimberly, Archer, Jacob, Leventhal, Shanna S, Wilson, Drew, Shaia, Carl, Randall, Samantha, Khandhar, Amit P, Krieger, Kyle, Hsiang, Tien-Ying, Gale, Michael, Berglund, Peter, Fuller, Deborah Heydenburg, Feldmann, Heinz, Erasmus, Jesse H
Publicado em 2022Texto